Feature | March 18, 2011| Mladen I. Vidovich, M.D, FACC, FSCAI

Radial May Benefit From Power Injectors, 4 French Angiography

Down-sizing is right-sizing when it comes to transradial procedures

Medrads Avanta power contrast injection system. Power injectors allow smaller 4 French catheters to be used when performing radial access procedures.

With power contrast injectors, cath lab operators can use a hand controller unit, allowing increased distance from the X-ray source, significantly reducing radiation exposure to the operator. Pictured is the Acist CVi system.

The hand controller from the Acist CVi system.

Radial artery occlusion rate during transradial access procedures is strongly related to sheath and catheter size. Although worldwide most experienced practitioners (90 percent) use 5 and 6 French systems(1), high-quality coronary artery opacification can be obtained with 4 French systems. However, high-flow states (arteriovenous [AV] fistulae in hemodialysis patients), large coronaries encountered in non-ischemic cardiomyopathy or cold, high-viscosity contrast media frequently impact image quality.

Currently, there are two power contrast injection systems specifically designed for use in the cardiac catheterization laboratories: Medrad’s Avanta and the Acist CVi. Many cardiac catheterization laboratories use these systems, since they provide reliable injection rates and optimal coronary opacification using smaller French systems.

These devices are usually table-mounted and have sufficient contrast storage to allow performance of several procedures during a regular day. This significantly reduces contrast waste between procedures. The “multi-patient” disposable part is then attached to the single-patient disposable unit. Compared to the well-known but bulky traditional manifolds frequently seen in cardiac catheterization laboratories, these systems are quite nimble. Once the tubing from the power injector is attached to the coronary catheter, the operator only needs to hold the hand controller unit. This is not trivial, since it allows increased distance from the radiation source and significantly reduces radiation exposure to the operator. Another very tangible benefit is the seamless transition from injection to pressure tracing – since there is no manifold, there are no stopcocks to turn.

Published studies support the use of these devices and show contrast volume is consistently reduced and equivalent vessel opacification can be achieved.(2) When comparing 6 and 4 French systems, one study found no difference in image quality and less contrast use with the 4 French system.(3) Despite these advantages, only a minority of operators currently use 4 French systems.

In our opinion, since radial artery occlusion rates are associated with catheter size, we recommend using the smallest catheter necessary to obtain optimal coronary opacification. “Down-sizing” diagnostic catheters goes hand in hand with “right-sizing” interventional equipment. A large percentage of percutaneous coronary interventions can be performed with 5 French guiding catheters, and power injectors are exceptionally well suited for interventional use.

References:
1. Bertrand, O. F., S. V. Rao, et al. (2010). “Transradial approach for coronary angiography and interventions: results of the first international transradial practice survey.” JACC Cardiovascular Interventions, 2010, 3 (10): 1022-1031.

2. Chahoud, G., S. Khoukaz, et al. “Randomized comparison of coronary angiography using 4 French catheters: 4 French manual versus ‘Acisted’ power injection technique.” Catheterization and Cardiovascular Interventions, 2001, 53 (2): 221-224.

3. Hou, L., Y. D. Wei, et al. “Comparative study of 4 French catheters using the Acist variable rate injector system versus 6 French catheters using hand manifold in diagnostic coronary angiography via transradial approach.” Chinese Medical Journal (Engl), 2010, 123 (11): 1373-1376.

Related Content

heart attack patients, rescue PCI, transradial and transfemoral approach, Perelman School of Medicine
News | Vascular Access| January 04, 2016
January 4, 2016 — In a comparison of bleeding complications and mortality between transradial and transfemoral...
radial access
Feature | Radial Access| December 29, 2015
December 29, 2015 — Although using the radial artery as the access point for angioplasty has been linked to reduced b
Precision Image Analysis, PIA, cardiac MRI post-processing, Core Lab, RSNA 2015
Technology | Cardiac Imaging| December 15, 2015
Precision Image Analysis Inc. (PIA) announced a dramatic expansion of its capabilities as a provider of medical imaging...
ThinkRadial, Merit Medical Systems, Vascular Training Model

2015 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) attendees demo the ThinkRadial Vascular Training Model. Image courtesy of Merit Medical Systems Inc.

News | Radial Access| November 17, 2015
Merit Medical Systems Inc. and its ThinkRadial education program now offers a new vascular training model at events...
Sponsored Content | Videos | Radial Access| October 30, 2015
Sunil Rao, M.D., associate professor of medicine and a member in the Duke University Clinical Research Institute, a l
transradial access, TRI, DRAGON trial, TCT 2015, non-inferiority, transfemoral access, TFO
Feature | Radial Access| October 18, 2015
Results from a prospective randomized trial of transradial (TRI) versus transfemoral (TFO) access in patients...
Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors| October 01, 2015
Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline Catheter with MST...
ESC guidelines, radial approach, percutaneous coronary intervention, PCI, acute coronary syndrome, ACS
News | Radial Access| September 18, 2015
For the first time, European Society of Cardiology (ESC) guidelines give the highest degree of recommendation for the...
News | Cath Lab| August 26, 2015
August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report in
Feature | March 24, 2015
atients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not...
Overlay Init